ESMO26: Standard dosing prevails over 12-week checkpoint inhibitors in MOIO trial Pharmaceutical Technology 5d
Acumen’s Alzheimer’s drug fails in phase II; stock plummets BioWorld 2d Alzheimer's Health Article paywall
Philips launches HyperVue Integrated System in the U.S., bringing advanced coronary imaging and physiology into the cathlab Toronto Star 2d Consumer Electronics Philips Electronics
Anthropic acquires biotech startup exploring AI-led drug development European Pharmaceutical Review 2d Biotech Anthropic AI
